Wedbush Brokers Increase Earnings Estimates for ZNTL
Zentalis Pharmaceuticals, Inc. (NASDAQ:ZNTL – Free Report) – Stock analysts at Wedbush boosted their Q2 2025 earnings per share (EPS) estimates for Zentalis Pharmaceuticals in a research report issued to clients and investors on Thursday, May 15th. Wedbush analyst R. Driscoll now forecasts that the company will earn ($0.57) per share for the quarter, up […]
Zentalis Pharmaceuticals, Inc. (NASDAQ:ZNTL – Free Report) – Stock analysts at Wedbush boosted their Q2 2025 earnings per share (EPS) estimates for Zentalis Pharmaceuticals in a research report issued to clients and investors on Thursday, May 15th. Wedbush analyst R. Driscoll now forecasts that the company will earn ($0.57) per share for the quarter, up […]
